Zhou R - Search Results

1

The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.

Tanzhu G, Chen L, Xiao G, Shi W, Peng H, Chen D, Zhou R. Tanzhu G, et al. Among authors: zhou r. Cell Death Discov. 2022 Oct 11;8(1):416. doi: 10.1038/s41420-022-01206-y. Cell Death Discov. 2022. PMID: 36220835 Free PMC article. Review.

2

Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma.

Peng H, Li Z, Fu J, Zhou R. Peng H, et al. Among authors: zhou r. Cancer Manag Res. 2019 Apr 2;11:2653-2661. doi: 10.2147/CMAR.S192095. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114328 Free PMC article.

3

Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis.

Peng H, Li Z, Long Y, Li J, Liu Z, Zhou R. Peng H, et al. Among authors: zhou r. Biosci Rep. 2019 Sep 20;39(9):BSR20190691. doi: 10.1042/BSR20190691. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31484795 Free PMC article.

4

Cdk5-mediated Drp1 phosphorylation drives mitochondrial defects and neuronal apoptosis in radiation-induced optic neuropathy.

Rong R, Xia X, Peng H, Li H, You M, Liang Z, Yao F, Yao X, Xiong K, Huang J, Zhou R, Ji D. Rong R, et al. Among authors: zhou r. Cell Death Dis. 2020 Sep 3;11(9):720. doi: 10.1038/s41419-020-02922-y. Cell Death Dis. 2020. PMID: 32883957 Free PMC article.

5

Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis.

Liu Z, Jiang Z, Meng L, Yang J, Liu Y, Zhang Y, Peng H, Li J, Xiao G, Zhang Z, Zhou R. Liu Z, et al. Among authors: zhou r. J Oncol. 2021 Jun 3;2021:5518717. doi: 10.1155/2021/5518717. eCollection 2021. J Oncol. 2021. PMID: 34188680 Free PMC article.

6

Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application.

Xiao G, Liu Z, Gao X, Wang H, Peng H, Li J, Yang L, Duan H, Zhou R. Xiao G, et al. Among authors: zhou r. Immunotherapy. 2021 Aug;13(12):1031-1051. doi: 10.2217/imt-2020-0262. Epub 2021 Jul 7. Immunotherapy. 2021. PMID: 34231370 Review.

7

Xiao G, Gao X, Li L, Liu C, Liu Z, Peng H, Xia X, Yi X, Zhou R. Xiao G, et al. Among authors: zhou r. J Oncol. 2021 Dec 18;2021:3766685. doi: 10.1155/2021/3766685. eCollection 2021. J Oncol. 2021. PMID: 34961815 Free PMC article.

8

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients.

Tanzhu G, Li N, Li Z, Zhou R, Shen L. Tanzhu G, et al. Among authors: zhou r. Front Oncol. 2022 Feb 14;12:779168. doi: 10.3389/fonc.2022.779168. eCollection 2022. Front Oncol. 2022. PMID: 35237509 Free PMC article.

9

The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.

Chu X, Niu L, Xiao G, Peng H, Deng F, Liu Z, Wu H, Yang L, Tan Z, Li Z, Zhou R. Chu X, et al. Among authors: zhou r. Front Immunol. 2022 May 25;13:875488. doi: 10.3389/fimmu.2022.875488. eCollection 2022. Front Immunol. 2022. PMID: 35693805 Free PMC article.

10

Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.

Xiao G, Li L, Tanzhu G, Liu Z, Gao X, Wan X, Xiao D, Chen L, Xia X, Zhou R. Xiao G, et al. Among authors: zhou r. J Immunother Cancer. 2023 Mar;11(3):e006243. doi: 10.1136/jitc-2022-006243. J Immunother Cancer. 2023. PMID: 36868569 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,901 results

Search Page

Filters